Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
honestly, one wonders what's going on with the company when rehash articles and data are the only thing that indicate any sign of life. A pattern many stalled nanocaps in ph2 exhibit.
it's always something, isn't it?
it's been the same way with data, trials, money, etc. Nothing. How do you expect the Street to believe in Anavex?
I'll buy back some at 3.40
I was thinking the same thing when I saw the quote, and was going to respond in a similar fashion. It's actually a joke. How long have presentations and prs been saying that P2/3 is in preparation? As they say, time is money, and Anavex is wasting a lot of it. In this case, it's called "stock decay."
Indeed! I just remembered (while reading your post): It's a different CEO, one with experience in increasing shareholder value.
Three now. Don't really mean anything as far as data goes. Good exposure. Generate interest from potential investors. I would like to know about the TNGBC data.
He never spoke with anybody. Besides, if you read the article in the link, you might have noticed the correction in bold:
CORRECTION: Anavex Life Sciences expects to begin Phase 2 of clinical testing this year. A previous version of this column said it had begun Phase 2 testing.
Pete, why don't we know this? Why hasn't Anavex made the data crystal clear? Can you believe it? The board is still discussing the meaning of data, or, rather, what data means to management. And many here believe they still don't know; hence, Ariana.
I'd like to see Dan buy some shares on the open market, that's what I'd like.
of course. Chile is soooo like the States in many ways.
ditto here in Santiago, Chile. Thinking about taking my kids to--get this name--"California Cantina" for Thanksgiving dinner.
your analogy is bad. Bad science.
no worries
they do. TNBC.
Anyone think ONCS will present data at San Antonio Breast Cancer Symposium? Too late?
we do have a lot, don't we?
just because he has "the slows," to quote Lincoln, doesn't mean he's going to get it right. Wrongly, I'd say, based on the article, that they are struggling to come up with a sweet-spot cohort. And we wait.
probably because he realizes data are more ambiguous that initially thought. In the article, it states that they are STILL trying to understand who improved and why. Incredible. And--who knows?--we could be waiting for months before the Ph2/3 trials starts.
agreed about confidence. Six or seven patients, and it isn't quite clear why they have improved. Donc, a large, double-blind, placebo-controlled trial.
Last night, based on her tweet. Maybe she'd hung out too much with Missling; it's rubbing off.
We know now, right? Enough proof, right? Well, I say--enough talk Let's prove it now in a large Ph 2/3 trial. Why the wait?
We could be waiting months. Enrolling 300 patients, we could be well into 2019. Results? 2020.
gee, I never knew you were gone.
just curious, benny: why does quiet mean positive?